Hikma Pharmaceutical | HIK - Assets


Hikma Pharmaceutical reported $5.67B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Almirall EUR 2.37B 29.97M Jun/2026
argenx SE USD 10.03B 1.35B Jun/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
Autolus Therapeutics Ltd USD 493.23M 33.84M Jun/2026
Bayer EUR 113.47B 6.18B Sep/2026
Fresenius EUR 42.24B 401M Sep/2026
Genmab DKK 12.52B 139M Jun/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
GRIFOLS EUR 20.28B 191M Sep/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lakefront Biotherapeutics EUR 3.35B 21.24M Jun/2026
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 52.69B 383M Jun/2026
Orion EUR 2.03B 160.3M Sep/2026
Recordati EUR 5.37B 33.76M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
UCB EUR 18.16B 971M Dec/2025